A 17-year-old Aboriginal girl from a remote community has established rheumatic heart disease with moderate mitral regurgitation. She has a history of definite acute rheumatic fever aged 10 and 13 years. She is otherwise well and not pregnant. According to current Australian guidelines, which long-term strategy best reduces her risk of further rheumatic fever episodes and progression of valve disease?